Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 172.40 -0.95 (-0.55%) | NSE 172.59 -0.96 (-0.55%) | Trade | Add

BSE Live

Jan 14, 12:37

172.40 -0.95 (-0.55%)

Volume

AVERAGE VOLUME

5-Day

35,184

10-Day

31,867

30-Day

35,074

6,761

Prev. Close

173.35
Open Price

172.95

Bid Price (Qty.)
172.45 (692)
Offer Price (Qty.)
172.75 (15)

NSE Live

Jan 14, 12:37

172.59 -0.96 (-0.55%)

Volume

AVERAGE VOLUME

5-Day

705,459

10-Day

611,798

30-Day

625,993

213,408

Prev. Close

173.55
Open Price

172.69

Bid Price (Qty.)
172.59 (692)
Offer Price (Qty.)
172.66 (27)

Financials

Print/Copy to Excel : Go

Balance Sheet of Marksans Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	36.78	36.78	35.94	35.94	35.94
Total Share Capital	50.28	50.28	49.44	49.44	49.44
Reserves and Surplus	110.81	100.01	92.41	76.98	70.19
Total Reserves and Surplus	110.81	100.01	92.41	76.98	70.19
Total Shareholders Funds	161.09	150.29	141.85	126.42	119.63
Minority Interest	0.91	0.69	0.27	-0.04	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	322.59	337.30	278.08	274.28	281.78
Deferred Tax Liabilities [Net]	12.21	11.96	10.86	8.50	8.09
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	334.80	349.26	288.94	282.78	289.87
CURRENT LIABILITIES
Short Term Borrowings	101.44	59.24	59.79	44.44	22.08
Trade Payables	59.46	81.08	68.64	44.61	33.19
Other Current Liabilities	0.00	0.01	0.01	0.01	0.01
Short Term Provisions	0.09	1.03	2.68	0.70	4.54
Total Current Liabilities	160.99	141.36	131.11	89.75	59.83
Total Capital And Liabilities	657.79	641.60	562.18	498.91	469.33
ASSETS
NON-CURRENT ASSETS
Tangible Assets	173.62	185.63	191.06	138.53	124.87
Intangible Assets	218.10	194.83	79.27	1.28	0.00
Capital Work-In-Progress	0.00	0.00	0.00	0.00	0.00
Fixed Assets	391.72	380.46	270.33	139.81	124.87
Non-Current Investments	10.00	0.00	0.00	0.00	0.01
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	2.40
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.21	0.48	1.08	1.90	1.90
Total Non-Current Assets	401.92	380.94	271.41	141.71	129.17
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	104.52	119.08	139.43	123.93	78.91
Trade Receivables	94.72	101.68	65.01	54.22	50.70
Cash And Cash Equivalents	35.50	22.34	61.59	158.69	197.61
Short Term Loans And Advances	21.12	17.55	24.74	20.35	12.94
OtherCurrentAssets	0.00	0.00	0.00	0.00	0.00
Total Current Assets	255.87	260.65	290.76	357.20	340.16
Total Assets	657.79	641.60	562.18	498.91	469.33
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.00	0.00	0.00	0.07
BONUS DETAILS
Bonus Equity Share Capital	0.00	0.00	0.00	0.00	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	10.00	0.00	0.00	0.00	0.01
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00